Who owns the JAMP PHARMA trademark?

The JAMP PHARMA trademark is owned by JAMP PHARMA CORPORATION.

What is the serial number for JAMP PHARMA?

The USPTO serial number for JAMP PHARMA is 79390054.

What is the registration number for JAMP PHARMA?

JAMP PHARMA is registered under USPTO registration number 7583174.

JAM

USPTO Trademark Record

REGISTERED

JAMP PHARMA

Q: What class is the JAMP PHARMA trademark registered in?

The JAMP PHARMA trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 035 (Advertising, business management & retail services).

SN 79390054·Reg 7583174·Filed Sep 27, 2023

Owner JAMP PHARMA CORPORATION

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Advertising; business management, organization and administration; office functions.

JAMP PHARMA (Serial No. 79390054), Registration No. 7583174, is a registered US trademark filed on Sep 27, 2023 by JAMP PHARMA CORPORATION. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 035 (Advertising, business management & retail services).

early section 8: December 03, 2030

Mark Intelligence

JAMP PHARMA (Reg. #7583174) is a registered US trademark that has been protecting its owner, JAMP PHARMA CORPORATION, since 2023. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 035 (Advertising, business management & retail services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Sep 27, 2023

SERIAL

79390054

REG#

7583174

REGISTERED

Dec 03, 2024

Owner

Applicant

JAMP PHARMA CORPORATION

Entity

Corporation

Address

1310 rue Nobel, Boucherville QC J4B 5H3

Country

Attorney

NameBrent E.. Routman

Law firm

Brent E.. Routman Merchant & Gould, P.C.

Docket

9555.USIB

Address

150 SOUTH 5TH STREET, Ste 2200, P.O. Box 2910, Minneapolis, MN 55402, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateSep 27, 2023

Serial Number79390054

Registration No.7583174

Registration DateDec 03, 2024

Status DateDec 03, 2024

Published for OppositionOct 01, 2024

Mark TypeDesign with words

Attorney Docket9555.USIB

Status DescriptionLive and registered

Filing Signals

FILED

2023

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

Class 035Advertising, business management & retail services

US codes: 100, 101, 102

Advertising; business management, organization and administration; office functions.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

18 events

REGISTERED-PRINCIPAL REGISTER

Dec 03, 2024

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Dec 03, 2024

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Oct 01, 2024

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Oct 01, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Sep 11, 2024

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Aug 23, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 23, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 23, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Aug 23, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

REFUSAL PROCESSED BY IB

Jul 15, 2024

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

Jun 24, 2024

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Jun 24, 2024

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Jun 14, 2024

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Jun 03, 2024

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

May 18, 2024

ASSIGNED TO EXAMINER

APPLICATION FILING RECEIPT MAILED

Feb 27, 2024

APPLICATION FILING RECEIPT MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 23, 2024

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Feb 22, 2024

SN ASSIGNED FOR SECT 66A APPL FROM IB

JAMP PHARMA

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by JAMP PHARMA CORPORATION

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Brent E.. Routman

Resources

Company